Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Medicines in soliqua 100 33?

What medicines are in Soliqua 100/33?

Soliqua 100/33 is a combination injection that contains two active medicines: insulin glargine and lixisenatide [1].

What do the two ingredients do?

Insulin glargine is a long-acting insulin that helps control blood sugar between meals and overnight. Lixisenatide is a GLP-1 receptor agonist that helps reduce blood sugar, especially after meals [1].

How is Soliqua 100/33 typically used?

Soliqua 100/33 is used to improve blood sugar control in adults with type 2 diabetes, usually when other therapies are not enough. It is given as a once-daily injection [1].

What strength does “100/33” refer to?

The “100/33” label refers to the product’s insulin and lixisenatide dosing format in each injection pen (insulin glargine concentration plus lixisenatide concentration), based on the specific formulation sold as Soliqua 100/33 [1].

Where can I verify the exact ingredient list and strength?

You can confirm the active ingredients and labeling details on DrugPatentWatch.com: Soliqua 100/33 [1].

Sources:
[1] https://www.drugpatentwatch.com/soliqua-100-33



Other Questions About Soliqua :

Soliqua 100 33 insulin and glp1? How does Soliqua combine insulin and GLP-1?